Longevity & AgingArticle de rechercheAccès payant

How AI Could Turn Longevity Medicine Into Precision Prevention for Healthy Aging

A new review explores how AI can integrate multi-omic and wearable data to detect early aging deviations, while flagging equity, privacy, and overmedicalization risks.

lundi 16 novembre 2026 1 vue
Publié dans Presse Med
Glowing digital human silhouette surrounded by floating DNA helices, wearable sensor data streams, and aging-trajectory curves in a clinic

Résumé

This narrative review argues that artificial intelligence is accelerating longevity medicine's shift from treating disease to preserving function, resilience, and healthspan. AI systems can combine genomics, epigenomics, proteomics, microbiome data, digital biomarkers, lifestyle metrics, and environmental exposures to spot early departures from healthy aging trajectories before disease appears. That allows prevention tailored to biological rather than chronological age, using nutrition, metabolic optimization, sleep, stress management, continuous biosensing, and targeted therapeutics. The authors also describe a move from episodic, reactive care to continuously monitored, adaptive models. They caution that data fragmentation, unequal access, overmedicalization, privacy, and governance remain major hurdles. Interoperable data infrastructure, federated learning, and digital twins are presented as key enablers. The paper is a conceptual perspective, not a clinical trial, so its claims describe potential rather than demonstrated outcomes.

Résumé détaillé

Healthcare has traditionally focused on treating disease after it appears. Longevity medicine aims to change that by preserving physiological function, resilience, and healthspan. The challenge is that aging is shaped by many interacting biological and behavioral factors, which are hard to interpret without computational help.

This review by Green and Haykal examines how artificial intelligence may fill that gap. Based on the abstract, it is a narrative overview rather than a data-driven study. It discusses AI tools that can analyze genomics, epigenomics, proteomics, microbiome signatures, digital biomarkers, lifestyle metrics, and environmental exposures together.

The central argument is that these systems can detect early deviations from healthy aging trajectories before clinical disease emerges. This supports precision prevention guided by an individual's biological aging profile instead of chronological age. Proposed interventions include nutrition, metabolic optimization, sleep regulation, stress management, continuous biosensing, and targeted therapeutics. The authors also envision healthcare moving from reactive, episodic visits to adaptive, continuously monitored care focused on long-term resilience.

The authors identify significant obstacles: fragmented data, unequal access to preventive technologies, risks of overmedicalization, and privacy and governance concerns. They propose that interoperable data infrastructures, federated learning, and digital twin technologies will be essential for building clinically meaningful predictive models.

Important caveats apply. Only the abstract was available, so specific evidence, validation data, and named tools are not visible. The paper presents a forward-looking vision, and the abstract does not report evidence that AI-guided longevity strategies improve health outcomes or lifespan. Readers should treat the claims as potential and await prospective validation.

Principales conclusions

  • AI can integrate genomic, epigenomic, proteomic, microbiome, wearable, lifestyle, and environmental data to detect early deviations from healthy aging.
  • Prevention can be tailored to biological aging profiles rather than chronological age alone.
  • Proposed AI-guided levers include nutrition, metabolic optimization, sleep, stress management, continuous biosensing, and targeted therapeutics.
  • Key risks include data fragmentation, unequal access, overmedicalization, privacy concerns, and unresolved governance questions.
  • Interoperable infrastructure, federated learning, and digital twins are positioned as essential for clinically meaningful predictive models.

Méthodologie

This appears to be a narrative review or perspective article, based on the abstract alone. No data collection, systematic search method, or quantitative analysis is described. Conclusions are conceptual and synthesize existing technologies and themes.

Limites de l'étude

Only the abstract was reviewed, so the depth of evidence, specific AI models, and supporting citations cannot be assessed. The paper is not a clinical study and does not appear to show that AI-driven strategies improve outcomes or lifespan. Authors are from private dermatology and laser practices, and the scope may reflect a particular clinical perspective.

Ce résumé vous a plu ?

Recevez les dernières recherches sur la longévité dans votre boîte de réception chaque semaine.

Saisissez votre e-mail pour vous abonner :